Whole-body FDG-PET imaging in the management of patients with cancer

This publication has 112 references indexed in Scilit:

• Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin's Lymphomas (NHL)
  Cancer Biotherapy & Radiopharmaceuticals, 2001
• PET Scanning in Malignancy: Infant, Adolescent or Mature Citizen?
  Annals of Surgery, 2001
• Whole-Body FDG Positron Emission Tomographic Imaging for Staging Esophageal Cancer
  Clinical Nuclear Medicine, 2000
• Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic Patient
  The Laryngoscope, 2000
• Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose for the differentiation of chronic pancreatitis and pancreatic cancer
  British Journal of Surgery, 1999
• Liver Resection for Metastatic Colorectal Cancer: Assessing the Risk of Occult Irresectable Disease
  Journal of the American College of Surgeons, 1999
• Staging of the Axilla in Breast Cancer
  Annals of Surgery, 1998
• Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose
  JNCI Journal of the National Cancer Institute, 1996
• Positron emission tomography in the detection and management of metastatic melanoma
  Melanoma Research, 1996
• Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-Glucose
  Journal of Computer Assisted Tomography, 1993